These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9239501

  • 1. In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin.
    Erwin ME, Varnam D, Jones RN.
    Diagn Microbiol Infect Dis; 1997 Jun; 28(2):93-100. PubMed ID: 9239501
    [Abstract] [Full Text] [Related]

  • 2. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F, Baquero F.
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
    Jones RN, Erwin ME, Barrett MS, Johnson DM, Briggs BM.
    Diagn Microbiol Infect Dis; 1991 Mar; 14(4):301-9. PubMed ID: 1889181
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.
    Neu HC, Chin NX, Huang HB.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):566-73. PubMed ID: 8460925
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the in vitro antimicrobial activity of cefepime compared to other broad-spectrum beta-lactams tested against recent clinical isolates from 10 Chinese hospitals. Chinese Antimicrobial Resistance Study Group.
    Xu Y, Chen M, Biedenbach DJ, Deshpande LM, Jones RN.
    Diagn Microbiol Infect Dis; 1999 Oct; 35(2):135-42. PubMed ID: 10579094
    [Abstract] [Full Text] [Related]

  • 6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F.
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [Abstract] [Full Text] [Related]

  • 7. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
    Murphy SP, Erwin ME, Jones RN.
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):49-55. PubMed ID: 7867299
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T, Otsuki M, Hatano K, Nishihara Y.
    Chemotherapy; 1994 Sep; 40(3):167-82. PubMed ID: 8205935
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
    Hata K, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1894-901. PubMed ID: 1416879
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K, Mathai D, Biedenbach DJ, Lewis MT, Gales AC, Jones RN.
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C.
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [Abstract] [Full Text] [Related]

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Fujime M, Fujita K, Shigeta S, Watanabe J, Igari J, Ogiwara M, Ishibashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Matsumoto T, Kashitani F, Murai M, Ooe H, Nishikawa M, Watanabe K, Kobayashi Y, Uchida H, Oka T, Mochida C.
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.